Yuli W. Wang

Beijing, 100034, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 30 publications

Long-Term Prognosis and Impact Factors of Metoprolol Treatment in Children with Vasovagal Syncope.

Long-Term Prognosis and Impact Factors of Metoprolol Treatment in Children with Vasovagal Syncope.

Journal: Biomedicines

Published: November 21, 2025

Multivariate predictive model of the therapeutic effects of metoprolol in paediatric vasovagal syncope: a multi-centre study.

Multivariate predictive model of the therapeutic effects of metoprolol in paediatric vasovagal syncope: a multi-centre study.

Journal: EBioMedicine

Published: August 06, 2024

Serum uric acid predicts therapeutic response to midodrine hydrochloride in children with vasovagal syncope: a pilot study.

Serum uric acid predicts therapeutic response to midodrine hydrochloride in children with vasovagal syncope: a pilot study.

Journal: European journal of pediatrics

Published: August 19, 2023

Plasma human growth cytokines in children with vasovagal syncope.

Plasma human growth cytokines in children with vasovagal syncope.

Journal: Frontiers in cardiovascular medicine

Published: August 29, 2022

Spectrum of underlying diseases in syncope and treatment of neurally-mediated syncope in children and adolescents over the past 30 years: A single center study.

Spectrum of underlying diseases in syncope and treatment of neurally-mediated syncope in children and adolescents over the past 30 years: A single center study.

Journal: Frontiers in cardiovascular medicine

Published: August 15, 2022

Clinical Efficacy of Empirical Therapy in Children with Vasovagal Syncope.

Clinical Efficacy of Empirical Therapy in Children with Vasovagal Syncope.

Journal: Children (Basel, Switzerland)

Published: July 01, 2022

Twenty-Four-Hour Urinary Sodium Excretion Predicts Therapeutic Effectiveness of Oral Rehydration Saline in Pediatric Vasovagal Syncope.

Twenty-Four-Hour Urinary Sodium Excretion Predicts Therapeutic Effectiveness of Oral Rehydration Saline in Pediatric Vasovagal Syncope.

Journal: Children (Basel, Switzerland)

Published: May 19, 2022

Baroreflex sensitivity predicts therapeutic effects of metoprolol on pediatric postural orthostatic tachycardia syndrome.

Baroreflex sensitivity predicts therapeutic effects of metoprolol on pediatric postural orthostatic tachycardia syndrome.

Journal: Frontiers in cardiovascular medicine

Published: April 28, 2022

Baseline Corrected QT Interval Dispersion Is Useful to Predict Effectiveness of Metoprolol on Pediatric Postural Tachycardia Syndrome.

Baseline Corrected QT Interval Dispersion Is Useful to Predict Effectiveness of Metoprolol on Pediatric Postural Tachycardia Syndrome.

Journal: Frontiers in cardiovascular medicine

Published: November 03, 2021

Risk factors of sitting-induced tachycardia syndrome in children and adolescents.

Risk factors of sitting-induced tachycardia syndrome in children and adolescents.

Journal: PloS one

Published: October 09, 2021

Impact of Comorbidities on the Prognosis of Pediatric Postural Tachycardia Syndrome.

Impact of Comorbidities on the Prognosis of Pediatric Postural Tachycardia Syndrome.

Journal: International journal of general medicine

Published: September 28, 2021

Sitting-induced hemodynamic changes and association with sitting intolerance in children and adolescents: a cross-sectional study.

Sitting-induced hemodynamic changes and association with sitting intolerance in children and adolescents: a cross-sectional study.

Journal: Scientific reports

Published: March 14, 2020

Showing 1-12 of 30

Last Updated: 09/26/2026